Jeffrey E. Lee, M.D. - Surgical Oncology

Dr.Lee, is Board Certified in General Surgery. His major clinical interests are pancreatic and endocrine tumors, and melanoma. His major laboratory interest involves investigation of the role of HLA class II genes in the immune response to cancer.

Education:

• Medical School: Stanford University, Stanford, CA
• Residency (General Surgery): Stanford University Medical Center, Stanford, CA
• Research Fellowship (Cancer Immunology): Stanford University, Stanford, CA
• Clinical Fellowship (Surgical Oncology): University of TX M.D. Anderson Cancer Center, Houston, TX

Selected References :

1. Lee JE, Evans DB. Pancreatic Adenocarcinoma. Current Surgery March/April 1995, 52(3):106-111.

2. Lee JE, Berger DH, El-Naggar AD, Hickey RC, Sellin RV, Gagel RF, Burgess MA Evans DB. Surgical management, DNA content and patient survival in adrenal cortical carcinoma. Surgery December 1995, 118(6):1090-1098.

3. Lee JE, Curley SA, Evans DB, Gagel RF, Hickey RC. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery December 1996, 120(6):1064-1071.

4. Lee JE, Lowy AM, Thompson WA, Lu M, Skibber JM, Evans DB, Curley SA, Mansfield PF, Reveille JD. Association of gastric adenocarcinoma with the Human Leukocyte antigen Class II gene DQBI*0301 Gastroenterology 1996, 111:426-432. Accompanying editorial: Rigas B. HLA and desease association: The case of gastric cancer. Gastroentrology August 1996, 111:523-526.

5. Lee JE, Evans DB. Advances in the diagnosis and treatment of gastointestinal neuroendocrine tumors. In: Advances in Surgical Oncology. Pollock RP, ed. Kluwer Academic Publishers (Norwell, MA, 1997). 227-238.